ISRCTN26088319.
Methods | Randomised clinical trial |
Participants | Participants with myelodysplastic syndrome, transfusion dependent, and life expectancy > 6 months |
Interventions | Liberal: to maintain haemoglobin concentration Restrictive: to maintain a haemoglobin level between 8.5 g/dL and 10 g/dL |
Outcomes | Percentage of compliance of pretransfusion haemoglobin levels and achievement of at least 2 g/dL difference between liberal and restrictive transfusion |
Notes | ‐ |